(Q52502513)

English

The beneficial effects of nafazatrom (BAYg6575) on experimental coronary thrombosis.

scientific article published in April 1984

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6702555

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/6702555

title

The beneficial effects of nafazatrom (BAYg6575) on experimental coronary thrombosis. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6702555

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/6702555

1 reference

M J Shea

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6702555

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/6702555

E M Driscoll

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6702555

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/6702555

J L Romson

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6702555

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/6702555

B Pitt

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6702555

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/6702555

B R Lucchesi

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6702555

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/6702555

language of work or name

English

0 references

publication date

1 April 1984

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6702555

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/6702555

published in

American Heart Journal

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6702555

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/6702555

volume

107

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6702555

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/6702555

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6702555

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/6702555

page(s)

629-637

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6702555

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/6702555

Identifiers

DOI

10.1016/0002-8703(84)90307-7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6702555

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/6702555

PubMed publication ID

6702555

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6702555

retrieved

2 May 2018

reference URL

http://europepmc.org/abstract/MED/6702555

ResearchGate publication ID

16492887

0 references

(Q52502513)

The beneficial effects of nafazatrom (BAYg6575) on experimental coronary thrombosis.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)